# Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy

> **Newsylist Open Intelligence Dossier** · First detected: 2026-11-08 06:29 UTC · Category: Business · Sources: 2 · Current Velocity: 1.06

## Key People, Organizations & Locations
Novartis, Failure

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| TCTMD.com | Full Lp(a)HORIZON Results Affirm Lack of Pelacarsen Benefit in Secondary Prevention | 2026-11-07 14:54 | [Source Link](https://news.google.com/rss/articles/CBMipAFBVV95cUxPd1RqaWFialNOOUdkZk5RVHFlLTdVZUlTMXpUMDNSNC1pWW50ZzFwbDZmOVVnUGZReFhwWnRwdW5rRXpxSnAwNlZPSUVMeFlUN1VVcHp5aGtEXzhVMnNaQ2szMjVaLVAtX29GRGdRd1NyZm56MWpZMDl6ZU0wME84d25KSktpYlZYalJrdlNycU1kU0kzTmRlby02RlBESk1pU19TNw?oc=5) |
| STAT | Why the latest heart drug failures should make us all more skeptical of AI hype | 2026-11-07 14:54 | [Source Link](https://news.google.com/rss/articles/CBMisgFBVV95cUxNcWRTRTRFXzg3M2F5SW4tTDNQOWFkcEY5aWhtNUNCNjlaM0hnVjlseFZyUDFNcnp1UkdINGRIV0FYNjR6Q0xWZXU5RWFTTVlSa0o1Y3hFenRlbTBja2xCU3QxXzRKand2XzUyN0hBYWNZU0gxcWlKMDczdFFvXzVFTU92anBhMEF3SzFaY29xWkp2OXgzclNybzlzSXBpUWtLOEsyVjhxU2E0M2d0U1pKUXJR?oc=5) |
| STAT | Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy | 2026-11-07 14:54 | [Source Link](https://news.google.com/rss/articles/CBMirgFBVV95cUxOYzZjRi0zQ2tqem9tc21wRDZpLUxuVzJpNVl5ZVkxQ2dVZnhHUm1IYVFsMDRjQU9tSzB3cnlXbnI5eUpaUmYydjhYeVZKUWNTcnBYQlVQS0ItMkxDTFFaMm1XWWxFSmdkUWdJVVFDOTJNMzEtVko4eEM0V0JWLXAwNzdnd1VPTTFUc2tMbmVxRUZ5d1dFOWNObFNOQzJrd2d2Y29kM2NLVWt5dERNNGc?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-11-08/failure-of-novartis-lp-a-drug-raises-questions-about-cardiovascular-strategy*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*
